SciSparc

Beyond's analysis on SciSparc

• 2026-07-27 — SciSparc shifts strategy to pursue the agentic AI market and establishes an AI‑cybersecurity advisory board

Recent news mentioning SciSparc

• 2026-08-05 — SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome
• 2026-07-31 — SciSparc: Subsidiary NeuroThera Labs' Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics
• 2026-07-29 — SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company
• 2026-07-27 — SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity

Appears alongside

• NeuroThera
• S&P 500

Browse the full archive →